Productive and latent HIV infection of microglia: virus and host wrestle for SUMOylation system control

This work examines the role of SUMOylation in productive and latent HIV infection of microglia, providing a proteomic and functional resource that characterizes how the host SUMO system is engaged during viral latency and reactivation in the central nervous system (CNS). The study addresses a critical obstacle to HIV cure efforts: the persistence of latent reservoirs in immunologically privileged tissues such as the CNS, where microglia represent a key cellular reservoir. Drawing on recent advances in the understanding of post-translational modifications, the authors focus on SUMOylation - covalent modification of lysine residues by small ubiquitin-related modifiers - and its capacity to regulate protein stability, localization and function in pathways that are central to innate immunity and transcriptional control. The research contextualizes SUMOylation within mechanisms known to support viral latency, including transcriptional repression mediated by nuclear cofactors and histone-modifying complexes.

Prior work identified a - viral latency complex - in microglia, involving CTIP2, histone deacetylases, transcription factors, and the SUMO E3 ligase TRIM28, suggesting that SUMO-dependent modification of host proteins contributes to maintenance of an inert viral state. Building on these insights, the study demonstrates that SUMO conjugation is induced by proviral HIV infection in a human microglia model and that viral reactivation correlates with a pronounced loss of SUMO conjugation. To interrogate these dynamics at scale, the investigators performed mass spectrometry, based SUMO proteomic analyses in a human latently infected microglia model (HC69) and compared protein expression and SUMOylation patterns between latent and reactivated states. These analyses identified and quantified changes in host protein expression and SUMOylation associated with latency and reactivation, revealing distinct protein populations whose function appears regulated by HIV-induced modulation of the SUMO pathway.

The findings implicate SUMOylation as a regulator of transcription factors (including those known to influence HIV promoter activity) and other nuclear proteins that could sustain transcriptional silence in microglia. By integrating proteomic profiling with functional interpretation, the study provides the first comprehensive proteomic resource describing nuclear SUMO responses to HIV infection in the CNS. This resource lays foundational groundwork for future mechanistic studies probing how manipulation of the SUMOylation system might influence viral persistence, immune recognition, and neuropathogenesis. Given the association of microglial infection with chronic inflammation and HIV-associated neurocognitive disorders, understanding SUMO-dependent processes in microglia has potential translational relevance for strategies aimed at diminishing reservoir persistence or modulating neuroinflammatory sequelae. Collectively, Langford and colleagues offer a targeted exploration of SUMO biology in microglial HIV latency, furnishing proteomic data and conceptual advances to guide subsequent research on host-virus interactions in the CNS.